Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. (May 2021)
- Record Type:
- Journal Article
- Title:
- Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. (May 2021)
- Main Title:
- Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis
- Authors:
- Maagdenberg, Hedy
Oosterom, Natanja
Zanen, Jolanda
Gemmati, Donato
Windsor, Rachael E.
Heil, Sandra G.
Esperón, Patricia
Jabeen, Shakila
Ruiz-Argüelles, Guillermo J.
Zolk, Oliver
Hoerning, Susanne
Sleurs, Charlotte
Lopéz-Lopéz, Elixabet
Moreno-Galván, Mónica
van den Heuvel-Eibrink, Marry M.
Maitland-van der Zee, Anke H.
Carleton, Bruce C. - Abstract:
- Graphical abstract: Highlights: 57 studies were included in this systematic review; 26 in the meta-analysis. A total of 34 SNPs were associated with (more severe) mucositis in ≥1 study. MTHFRc.677C > T was associated with more severe mucositis (OR 2.53, 95 %CI 1.48–4.32). MTRRc.66A > G was associated with mucositis (OR 2.08, 95 %CI 1.16–3.73). Current studies are heterogeneous in design with different case-control definitions. Abstract: Methotrexate (MTX), an important chemotherapeutic agent, is often accompanied with mucositis. The occurrence and severity are unpredictable and show large interindividual variability. In this study, we review and meta-analyze previously studied genetic variants in relation to MTX-induced mucositis. We conducted a systematic search in Medline and Embase. We included genetic association studies of MTX-induced mucositis in cancer patients. A meta-analysis was conducted for single nucleotide polymorphisms (SNPs) for which at least two studies found a statistically significant association. A total of 34 SNPs were associated with mucositis in at least one study of the 57 included studies. Two of the seven SNPs included in our meta-analysis were statistically significantly associated with mucositis: MTHFR c.677C > T (recessive, grade ≥3 vs grade 0–2, OR 2.53, 95 %CI [1.48–4.32], False Discovery Rate[FDR]-corrected p-value 0.011) and MTRR c.66A > G (overdominant, grade ≥1 vs grade 0, OR 2.08, 95 %CI [1.16–3.73], FDR-corrected p-value 0.042).
- Is Part Of:
- Critical reviews in oncology/hematology. Volume 161(2021)
- Journal:
- Critical reviews in oncology/hematology
- Issue:
- Volume 161(2021)
- Issue Display:
- Volume 161, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 161
- Issue:
- 2021
- Issue Sort Value:
- 2021-0161-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-05
- Subjects:
- Methotrexate -- Mucositis -- Gastrointestinal toxicity -- Pharmacogenomics -- Pediatric -- Adult -- Cancer
Oncology -- Periodicals
Hematology -- Periodicals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10408428 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.critrevonc.2021.103312 ↗
- Languages:
- English
- ISSNs:
- 1040-8428
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3487.479000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16890.xml